BioCure's ongoing work is borne out of biomaterial research and is currently directed to the following general therapeutic and technology areas:

Nanotechnology

Spine and Orthopedic

Medical devices (excluding ophthalmics)

Woundcare

This breadth, however, belies BioCure’s focus on specific and fully specified sponsored product development through manufacturing.

In this regard, our point of departure is almost always in a defined and focused product.

Our aim is to keep appraised of the needs of the market and individual companies, and work in collaboration with world-class commercial partners in the medical, biotechnology and pharmaceutical, from initial feasibility to regulatory approval and manufacture.

BioCure’s financial goal in a collaboration is to break-even through the clinical trial process and derive returns from the eventual manufacturing and sales of our co-developed products. These returns are principally reinvested in new research and collaborations.

Please contact us if you have any questions. We'd be happy to provide you with more information.